PHBID.US NeoRich BioPharma Tech Co., Limited
- Market cap
- USD 156K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Sep 2022.
Is PHBID.US undervalued?
Graham numberThe Graham number of NeoRich BioPharma Tech Co., Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NeoRich BioPharma Tech Co., Limited fundamental analysis
No fundamental analysis for NeoRich BioPharma Tech Co., Limited yet.
NeoRich BioPharma Tech Co., Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NeoRich BioPharma Tech Co., Limited
NeoRich BioPharma Tech Co., Limited operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for culti…
Full company profileNeoRich BioPharma Tech Co., Limited financial statements
NeoRich BioPharma Tech Co., Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 |
|---|---|---|
| Income Statement | ||
| Revenue | 0.00 | 0.00 |
| Operating Income | -753K | -1.07M |
| EBITDA | -3.76M | -828K |
| Net Income | -4.53M | -875K |
| EPS | -0.01 | 0.00 |
| Balance Sheet | ||
| Total Assets | 373K | 209K |
| Total Liabilities | 2.07M | 2.03M |
| Shareholders' Equity | -1.65M | -1.78M |
| Cash & Short-term Investments | 25.3K | 8.02K |
| Cash Flow | ||
| Operating Cash Flow | -206K | -427K |
| Capital Expenditure | 0.00 | 0.00 |
| Free Cash Flow | -206K | -427K |
| Ratios | ||
| ROA | -1,214.8% | -418.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
NeoRich BioPharma Tech Co., Limited dividends
NeoRich BioPharma Tech Co., Limited has not paid dividends in the last 2 fiscal years.
Last stock split: 1:2000 on Aug 12, 2026.
Who owns NeoRich BioPharma Tech Co., Limited
Ownership data of NeoRich BioPharma Tech Co., Limited is not available yet.
NeoRich BioPharma Tech Co., Limited company profile
- Company name
- NeoRich BioPharma Tech Co., Limited
- Ticker
- PHBID.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Fiscal year end
- September
- Address
- 2987 Blackbear Court, Coquitlam, BC, Canada, V3E 3A2
- Phone
- 702 803 9404
- Website
- pharmagreen.ca
About NeoRich BioPharma Tech Co., Limited
NeoRich BioPharma Tech Co., Limited operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America. The company's primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body. It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services. It sells its products through online stores, such as Amazon and Shopify. The company was formerly known as Pharmagreen Biotech Inc. and changed its name to NeoRich BioPharma Tech Co., Limited in April 2026. The company is headquartered in Coquitlam, Canada.
NeoRich BioPharma Tech Co., Limited management
2- Mr. Peter Wojcik B.A.President, CEO, Secretary, Treasurer & Director · born 1972
- Mr. Terry Kwan B.Com., C.A., CPACFO & Principal Accounting Officer · born 1948